Stemtech Corporation

STEK ·Healthcare, Medical Distribution, United States
Financial Statements › Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019 FY2018
Operating Activities
Net Income $-4.0M $-3.8M $-5.4M $-8.5M $-7.1M $-916.7K $-33.8K $-37.3K
Depreciation & Amortization $167.5K $344.5K $587.8K $447.4K $428.6K $430.3K — —
Depreciation — — — — — — — —
Amortization — — — — — — — —
Stock-Based Compensation $439.1K $440.3K $439.1K $4.0M $1.0M $450.5K — —
Net Cash from Operating Activities $-483.6K $-601.2K $-2.0M $-1.2M $-1.9M $-266.7K $-11.4K $-25.4K
Investing Activities
Capital Expenditures $0 $0 $0 — — $11.6K — —
Business Acquisitions — — — — — — — —
Net Cash from Investing Activities $0 $0 $0 — — $-11.6K — —
Financing Activities
Dividends Paid — — — — — — — —
Stock Repurchases — — — — — — — —
Net Cash from Financing Activities $460.0K $1.1M $1.6M $338.7K $2.6M $159.4K $3.5K $25.0K
Net Change in Cash $-17.1K $141.1K $-18.3K $-695.7K $695.1K $-117.2K $-7.9K $-351
Free Cash Flow $-483.6K $-601.2K $-2.0M — — $-278.3K — —
← Newer Page 1 of 2 Older →